Most Recent

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: Life Science Controversies of 2016

Life Science Controversies of 2016

By , , and | December 23, 2016

This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

0 Comments

image: Opinion: Ethical Considerations of “Three-Parent” Babies

Opinion: Ethical Considerations of “Three-Parent” Babies

By | December 22, 2016

Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.

0 Comments

image: Britain Set to Become First Country to Approve Three-Parent IVF

Britain Set to Become First Country to Approve Three-Parent IVF

By | December 16, 2016

Parliament voted to allow mitochondrial replacement therapy last year. This latest decision suggests we may see babies born from the technique in the country in 2017.

0 Comments

image: Three-Parent IVF Advances

Three-Parent IVF Advances

By | November 30, 2016

Differences in the replicative advantages conferred by some mitochondrial DNA haplotypes have implications for mitochondrial replacement therapy, researchers report. 

0 Comments

image: TS Picks: October 24, 2016

TS Picks: October 24, 2016

By | October 24, 2016

Theranos’s bad blood tests; presidential science lessons; “three-parent” babies

0 Comments

image: First MRT Baby Born

First MRT Baby Born

By | September 28, 2016

Scientists in Mexico achieved the infant’s conception using mitochondrial replacement therapy. 

2 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham